Dare Bioscience (DARE) delivered earnings and revenue surprises of 8.33% and 98.64%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

“I think the reality is we are probably in one of the biggest periods of geopolitical uncertainty and instability we have seen in our lifetimes,” Brian Schimpf, co-founder and CEO of defense tech ...

When retirement is nearing, you need to get your finances in order. If you weren't already, now is the time to get laser ...